Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?

被引:16
作者
Dolan, K
Morris, AI
Gosney, JR
Field, JK
Sutton, R
机构
[1] Univ Liverpool, Royal Liverpool Hosp, Dept Surg, Mol Genet & Oncol Grp, Liverpool L69 3BX, Merseyside, England
[2] Univ Liverpool, Royal Liverpool Hosp, Dept Med, Mol Genet & Oncol Grp, Liverpool L69 3BX, Merseyside, England
[3] Univ Liverpool, Royal Liverpool Hosp, Dept Pathol, Mol Genet & Oncol Grp, Liverpool L69 3BX, Merseyside, England
关键词
classification; gastroesophaeal junction; loss of heterozygosity; subsite;
D O I
10.1111/j.1440-1746.2004.03280.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: Currently there are three different subsite classification systems for carcinomas in the region of the gastroesophaeal junction (GEJ), namely ICD-O, Munich and Liverpool. The aim of the present study was to compare clinicoepidemiological, pathological and molecular features of adenocarcinomas in the proximity of the GEJ, classified according to their position with respect to the GEJ initially, and then classified according to ICD-O, Munich and Liverpool classifications. Methods: Forty-seven adenocarcinomas in the proximity of the GEJ were subdivided into groups 1 (exclusively within esophagus), 2 (mainly within esophagus but extending distally across GEJ), 3 (equally present in esophagus and stomach) or 4 (mainly in stomach but extending proximally across GEJ), and analysis of their clinicoepidemiological, pathological and molecular features was performed. Molecular characterization included loss of heterozygosity (LOH) and microsatellite instability analyses. Results: Group 3 carcinomas were younger than other carcinomas in the proximity of the GEJ, but otherwise these carcinomas were similar in their clinicoepidemiological, pathological and molecular features. There were no significant differences between esophageal (groups 1 and 2) and gastric (groups 3 and 4) carcinomas as classified by ICD-O. Munich types I (groups 1 and 2), II (group 3) and III (group 4) carcinomas of the GEJ were also similar. LOH at the site of the Rb tumor suppressor gene and at 17p11.1-p12 was more common in GEJ (groups 2, 3 and 4) than lower third (group 1) esophageal carcinomas classified according to the Liverpool system. Conclusion: Overall, adenocarcinomas of the lower esophagus and adenocarcinomas involving the GEJ have similar clinicoepidemiological, pathological and molecular features no matter which subsite classification is used, adding further evidence that they represent the same disease. (C) 2004 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 44 条
[11]  
Dolan K, 1997, ONCOL REP, V4, P1319
[12]   Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites [J].
Dolan, K ;
Garde, J ;
Gosney, J ;
Sissons, M ;
Wright, T ;
Kingsnorth, AN ;
Walker, SJ ;
Sutton, R ;
Meltzer, SJ ;
Field, JK .
BRITISH JOURNAL OF CANCER, 1998, 78 (07) :950-957
[13]   Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis [J].
DosSantos, NR ;
Seruca, R ;
Constancia, M ;
Seixas, M ;
SobrinhoSimoes, M .
GASTROENTEROLOGY, 1996, 110 (01) :38-44
[14]  
Fléjou JF, 1999, J CLIN PATHOL-MOL PA, V52, P263
[15]  
Gleeson CM, 1996, ONCOGENE, V12, P1653
[16]   Allelotype analysis of adenocarcinoma of the gastric cardia [J].
Gleeson, CM ;
Sloan, JM ;
McGuigan, JA ;
Ritchie, AJ ;
Weber, JL ;
Russell, SEH .
BRITISH JOURNAL OF CANCER, 1997, 76 (11) :1455-1465
[17]   Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia [J].
Gleeson, CM ;
Sloan, JM ;
McManus, DT ;
Maxwell, P ;
Arthur, K ;
McGuigan, JA ;
Ritchie, AJ ;
Russell, SEH .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :277-286
[18]   Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction - An immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45MI [J].
Glickman, JN ;
Wang, H ;
Das, KM ;
Goyal, RK ;
Spechler, SJ ;
Antonioli, D ;
Odze, RD .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (01) :87-94
[19]  
Hansen S, 1997, INT J CANCER, V71, P340, DOI 10.1002/(SICI)1097-0215(19970502)71:3<340::AID-IJC5>3.0.CO
[20]  
2-Y